These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 29081308)
1. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION. Tordrup D; Chouaid C; Cuijpers P; Dab W; van Dongen JM; Espin J; Jönsson B; Léonard C; McDaid D; McKee M; Miguel JP; Patel A; Reginster JY; Ricciardi W; Rutten-van Molken M; Rupel VP; Sach T; Sassi F; Waugh N; Bertollini R Int J Technol Assess Health Care; 2017 Jan; 33(6):609-619. PubMed ID: 29081308 [TBL] [Abstract][Full Text] [Related]
2. A scoping review of health economic evaluation in the World Health Organization Eastern Mediterranean region. Sharkawy MN; Dastan I Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):877-884. PubMed ID: 34024232 [No Abstract] [Full Text] [Related]
3. Health technology assessment: research trends and future priorities in Europe. Nielsen CP; Funch TM; Kristensen FB J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525 [TBL] [Abstract][Full Text] [Related]
4. The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries' Health Economics Practitioners: A Commentary. Adeagbo CU; Rattanavipapong W; Guinness L; Teerawattananon Y Value Health; 2018 May; 21(5):569-572. PubMed ID: 29753354 [TBL] [Abstract][Full Text] [Related]
5. Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology. Inotai A; Pékli M; Jóna G; Nagy O; Remák E; Kaló Z BMC Health Serv Res; 2012 Sep; 12():332. PubMed ID: 22999574 [TBL] [Abstract][Full Text] [Related]
6. The use of economic evaluations in NHS decision-making: a review and empirical investigation. Williams I; McIver S; Moore D; Bryan S Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906 [TBL] [Abstract][Full Text] [Related]
7. Health economic evidence gaps and methodological constraints in low back pain and neck pain: Results of the Research Agenda for Health Economic Evaluation (RAHEE) project. van Dongen JM; Ketheswaran J; Tordrup D; Ostelo RWJG; Bertollini R; van Tulder MW Best Pract Res Clin Rheumatol; 2016 Dec; 30(6):981-993. PubMed ID: 29103555 [TBL] [Abstract][Full Text] [Related]
8. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project. Lord J; Willis S; Eatock J; Tappenden P; Trapero-Bertran M; Miners A; Crossan C; Westby M; Anagnostou A; Taylor S; Mavranezouli I; Wonderling D; Alderson P; Ruiz F Health Technol Assess; 2013 Dec; 17(58):v-vi, 1-192. PubMed ID: 24325843 [TBL] [Abstract][Full Text] [Related]
9. A research roadmap for complementary and alternative medicine - what we need to know by 2020. Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850 [TBL] [Abstract][Full Text] [Related]
10. From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review. Ku Abd Rahim KN; Kamaruzaman HF; Dahlui M; Wan Puteh SE Value Health Reg Issues; 2020 May; 21():91-99. PubMed ID: 31698173 [TBL] [Abstract][Full Text] [Related]
11. A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Sullivan SM; Tsiplova K; Ungar WJ Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):599-607. PubMed ID: 27659998 [TBL] [Abstract][Full Text] [Related]
12. Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries. ; Heintz E; Gerber-Grote A; Ghabri S; Hamers FF; Rupel VP; Slabe-Erker R; Davidson T Pharmacoeconomics; 2016 Jan; 34(1):59-76. PubMed ID: 26446858 [TBL] [Abstract][Full Text] [Related]
13. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Tantivess S; Teerawattananon Y; Mills A Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793 [TBL] [Abstract][Full Text] [Related]
14. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey. Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S; Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485 [TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
16. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe. Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171 [TBL] [Abstract][Full Text] [Related]
17. Methodological reviews of economic evaluations in health care: what do they target? Hutter MF; Rodríguez-Ibeas R; Antonanzas F Eur J Health Econ; 2014 Nov; 15(8):829-40. PubMed ID: 23974963 [TBL] [Abstract][Full Text] [Related]
18. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level. Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647 [TBL] [Abstract][Full Text] [Related]
19. Allocating resources. Drummond MF Int J Technol Assess Health Care; 1990; 6(1):77-92. PubMed ID: 2113892 [TBL] [Abstract][Full Text] [Related]